Cardiovascular Disease

Cardiovascular Disease

Schema of ARG1 and NOS2 metabolic pathways

At CD BioSciences, we always focus on the needs of our customers and recognize that careful planning and perfect execution are key factors to the success of your clinical development plan. Therefore, empowered by decades of experience, we have built specific knowledge in the cardiovascular and metabolic disease fields. For every stage, every question, we will set up a professional clinical development team, who will help select the process and technology that meet your clinical research goals. Our vision is to guide you from preclinical to clincal to help you bring new therapies to market with success and ultimately improve the quality of life for people around the world.

Cardiovascular Portfolio

CD BioSciences' cardiovascular team has extensive experience and knowledge in cardiovascular disease progression, scientific methodology, and evolving regulatory requirements, which are necessary to bring medicines to treat or prevent heart disease to the market. We uncover new opportunities for cardiovascular drug development for a variety of cardiovascular diseases. These diseases fall into three main categories: cardiometabolic sisease, heart disease and vascular disorders.

Cardiometabolic Disease Heart Disease Vascular Disorders
  • Diabetes Type 2
  • Dyslipidemia
  • Hypercholesterolemia
  • Hypocholesterolemia
  • Kidney Disease
  • Nonalcoholic Steatohepatitis (NASH)
  • Obesity
  • Angina
  • Atrial Fibrillation
  • Coronary Artery Disease
  • Ischemic Heart Disease
  • Heart Failure
  • High-risk CVD
  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Angioplasty
  • Aortic Aneurysm
  • Atherosclerosis
  • Myocardial Ischemia
  • Pulmonary Arterial Hypertension
  • Peripheral Artery Disease
  • Stroke
  • Vascular Disease
  • Venous Thromboembolism

Therapeutic Expertise

We have extensive knowledge in therapeutic development. From a complete IND support program, early preclinical drug development to clinical and commercial manufacture and release, we provide a wide range of standards and specialized laboratory services to complement and enhance drug development programs at every stage. Thanks to our experienced professionals, we meet the needs of both small and large molecule development:

  • Small Molecule
  • Peptide
  • Antibody
  • Biosimilar
  • Cellular Therapy
  • Gene Therapy
  • Vaccine
  • Biologics
  • Device
  • Diagnostic Kit

End-to-end Phase I–IV Package

We provide comprehensive preclinical and clinical development services and solutions for cardiovascular drug development. From research design, lead optimization to product launch, commercialization, CD BioSciences has the expertise and the only resources you need to help manage molecular complexity and help you realize the full potential of your program.

Explore each stage of our clinical services for a complete picture:

  • Bioanalytical Lab Testing
  • Clinical Pharmacology
  • Proof of Concept (POC) & Pivotal Clinical Research
  • Early Phase Trials
  • Phase IIa Trials
  • Phase IIb Trials
  • Phase III Trials
  • Phase IIIb-IV Trials
  • Clinical Data Management Analysis and Reporting

CD BioSciences' scientists are dedicated to bringing together years of valuable experience to help our clients shorten the clinical trial journey. For further details, please don't hesitate to contact us.

Are you looking for a professional advisor for your trials?

Online Inquiry